Campbell's Company (NASDAQ: CPB) fell 6.2% on Thursday after the food manufacturer projected fiscal 2027 adjusted earnings per share of $1.65 to $1.80, a midpoint that sits 9% below the analyst consensus of $1.90. The case for relief from a matching fourth-quarter EPS print ran straight into guidance that few on the Street had penciled.
The fourth quarter showed a split result. Adjusted EPS of $0.39 came in at consensus, but revenue reached $2.1 billion, missing the $2.15 billion estimate and running 8% below the year-ago period. Part of that gap traces to calendar arithmetic: the comparable quarter a year earlier contained an extra week that management estimates contributed roughly 7% to those sales. Organic net sales still slipped 1%, driven by lower volume and mix.
The full fiscal year 2026 told a harder story. Revenue of $9.7 billion represented a 5% decline, and adjusted EPS fell 27% to $2.17. Adjusted gross profit margin contracted 210 basis points to 28.5%, with Campbell's attributing the compression to cost inflation and supply chain expenses, including tariff impacts. Cash from operations totaled $1.0 billion for the year.
The read-through on fiscal 2027
Looking ahead, Campbell's expects net sales to decline between 2% and 4%, and adjusted EBIT to fall between 7% and 12%. Those ranges span a wide set of outcomes. CEO Mick Beekhuizen said fourth-quarter and full-year results "reflect top-line softness and inflation-driven margin headwinds" and acknowledged that performance "is not where it needs to be," adding that the company is "taking decisive action to improve it."
The counterargument runs through two announcements that accompanied the guidance. Campbell's cut its quarterly dividend 36%, to $0.25 per share from $0.39, directing the freed capital toward debt reduction. The company also introduced a cost-savings program targeting $500 million of savings by fiscal 2030. An investor focused on balance sheet repair could read both moves as constructive, even against the weak guidance frame.
On balance, the numbers don't yet support that reading. A 9% miss at the guidance midpoint is not a rounding error, and the company's own forward brackets put EBIT contraction as deep as 12%. The risk is that the $500 million savings program, running through fiscal 2030, is too slow to arrest margin erosion before declining revenue compounds the problem. The tape's 6.2% verdict today reflects simpler arithmetic: a guidance midpoint of $1.73 against a $1.90 consensus is a gap that a dividend cut and a multi-year savings pledge don't immediately close.